Radcliffe Capital Management’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Radcliffe Capital Management’s Portfolio EQHA.WS Stock Details EQHA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-225,000	Closed	-$2.22M	–	1129
2022 Q3	$2.22M	Hold	225,000	–	–	0.05%	595
2022 Q2	$2.21M	Hold	225,000	–	–	0.05%	624
2022 Q1	$2.21M	Hold	225,000	–	–	0.05%	605
2021 Q4	$2.19M	Hold	225,000	–	–	0.06%	517
2021 Q3	$2.2M	Hold	225,000	–	–	0.06%	437
2021 Q2	$2.17M	Hold	225,000	–	–	0.07%	463
2021 Q1	$2.18M	Buy	+225,000	New	+$130K	0.09%	403

Other funds holding EQHA.WS

Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Radcliffe Capital Management's EQHA.WS Position: Q4 2022 in Review

Radcliffe Capital Management sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 225,000 shares — an estimated $2.22M sold.

Radcliffe Capital Management first reported a position in EQHA.WS in Q1 2021 and held it in 7 quarters. The position peaked at $2.22M in Q3 2022. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

Radcliffe Capital Management reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
Radcliffe Capital Management sold 225,000 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $2.22M.
Radcliffe Capital Management first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q1 2021 and held it in 7 quarters.
Radcliffe Capital Management's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $2.22M in Q3 2022.
1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.